Does Epstein-Barr virus infection confer selective advantage to malaria-infected children?
Watier
H
H
Laboratoire d'Immunologie, Faculté de Médecine, Tours, France.
Auriault
C
C
Capron
A
A
D000349:Africa / Q000453:epidemiology; D002051:Burkitt Lymphoma / Q000150:complications / Q000453:epidemiology / Q000276:immunology*; D002675:Child, Preschool; D015897:Comorbidity; D016207:Cytokines / Q000276:immunology; D006801:Humans; D007111:Immunity, Cellular; D015994:Incidence; D007223:Infant; D016753:Interleukin-10 / Q000276:immunology; D008288:Malaria / Q000150:complications / Q000453:epidemiology / Q000276:immunology*; D015995:Prevalence; D016036:Seroepidemiologic Studies
D016207:Cytokines; D016753:Interleukin-10